Research on Staphylococcus Aureus Lower Susceptibility to Vancomycin

LI Yan-Mei,XU Ze-Zhi,XU Zhen-bo
DOI: https://doi.org/10.13241/j.cnki.pmb.2011.01.021
2011-01-01
Abstract:With MRSA as one of the most prevalent pathogens in hospital and community,vancomycin becomes the last option for therapy of MRSA.As one of the hottest issue in medicine,emergence of non vancomycin sensitive Staphylococcus aureus had raised a dilemma for clinical therapy of MRSA.This study aims at reviewing the advance in research on non vancomycin sensitive Staphylococ-cus aureus.
What problem does this paper attempt to address?